10-KPeriod: FY1997

CARDINAL HEALTH INC Annual Report, Year Ended Jun 30, 1997

Filed September 29, 1997For Securities:CAH

Summary

Cardinal Health Inc.'s 1997 10-K filing provides a snapshot of the company's financial health and operational landscape as of June 29, 1997. The report indicates a company operating in the pharmaceutical distribution and healthcare services sector, demonstrating growth and strategic initiatives. Investors would find the information valuable for understanding the company's market position, revenue drivers, and potential risks and opportunities in the dynamic healthcare industry of the late 1990s. Key aspects likely covered in this filing would include detailed financial statements (balance sheet, income statement, cash flow), management's discussion and analysis of financial condition and results of operations, and a description of the business and its segments. The filing would also outline any material legal proceedings, risk factors, and forward-looking statements, offering a comprehensive view for potential and existing investors.

Key Highlights

  • 1The filing represents Cardinal Health's annual report for the fiscal year ending June 29, 1997, providing a comprehensive overview of its financial performance and business operations.
  • 2The company is a significant player in the pharmaceutical distribution and healthcare services industry, as indicated by the filing.
  • 3Investors can gain insights into Cardinal Health's revenue streams, operational efficiencies, and market strategies through the detailed financial statements and management discussions within the report.
  • 4The report likely addresses the company's growth trajectory and any strategic acquisitions or expansions undertaken during the reporting period.
  • 5An analysis of the 'Management's Discussion and Analysis of Financial Condition and Results of Operations' section is crucial for understanding the drivers of profitability and future outlook.
  • 6Disclosure of risk factors and legal proceedings provides essential information for investors to assess potential downsides and uncertainties associated with the company's business.

Frequently Asked Questions

Based on the context of a 1997 10-K filing for Cardinal Health Inc., the company is primarily involved in pharmaceutical distribution and healthcare services, serving as a crucial link in the healthcare supply chain.

Investors should focus on the consolidated financial statements, including the balance sheet, income statement, and cash flow statement, to understand the company's financial position, profitability, and liquidity. The Management's Discussion and Analysis (MD&A) section is also critical for insights into performance trends and future outlook.

While the specific risks are detailed within the full filing, typical risks for a company in this sector and era would include competition, regulatory changes in the healthcare and pharmaceutical industries, potential disruptions in the supply chain, and challenges related to managing large-scale distribution networks.

Yes, annual reports like this 10-K typically include discussions on the company's strategy for growth, which may involve organic expansion, strategic acquisitions, or diversification into new healthcare services, as outlined in the MD&A and business overview sections.